MacroGenics, Inc. has announced the appointment of Eric Risser as President and Chief Executive Officer, effective August 13, 2025. Risser succeeds Scott Koenig, who has served in this role for 24 years.
Company Information
Company
MacroGenics
Location
Rockville, Maryland, United States
About
MacroGenics, Inc. is a biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing innovative antibody-based therapeutics for the treatment of cancer. They have a strong emphasis on creating novel and differentiated oncology product candidates.
Fundz sees it the moment MacroGenics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.